PF-06260414 Uses, Dosage, Side Effects and more
PF-06260414 is under investigation in clinical trial NCT02070939 (Study To Evaluate Safety And Tolerability Of Single And Multiple Ascending Doses Of PF- 06260414 In Healthy Western And Japanese Male Subjects).
| Trade Name | PF-06260414 |
| Generic | PF-06260414 |
| Type | |
| Formula | C14H14N4O2S |
| Weight | Average: 302.35 Monoisotopic: 302.083746881 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
